Exhibition session 1 12.55 - 13.10

Choice 1:

Educational Resources Supporting Osteoporosis Treatment in Primary Care

This promotional educational session has been organised and fully funded by AMGEN and are intended for UK Healthcare Professionals only

-------

Choice 2:

FDB AnalyseRx: Next-level medicines optimisation

• Join our session to see FDB AnalyseRx live in action within the EMIS clinical system, with a demo hosted by Mike Fahey – our AnalyseRx Solution Lead.
• Learn about AnalyseRx, our new medicines optimisation solution designed to enable ongoing proactive medicines optimisation at a practice level
• Discover how AnalyseRx can support Clinical Pharmacists and PCNs in the delivery of Medicines Reviews, help with Therapeutic Monitoring and Safety Surveillance of patients at risk of medicines-related harm

This promotional educational session has been organised and fully funded by FDB and are intended for UK Healthcare Professionals only

-------

Choice 3:

Enteral Tubes and Medicines in Primary Care: Defining Best Practice by David Wright, Professor of Pharmacy Practice and Professor of Clinical Pharmacy

This promotional educational session has been sponsored by Rosemont Pharmaceuticals and are intended for UK Healthcare Professionals only

-------

Choice 4:

-------

Workshop session 1 13.15 - 13.55

Choice 1:

PINCER & The New Indicators - Speakers: Professor Tony Avery

This presentation will give an overview of PINCER and will provide an update on the national rollout of PINCER to GP practices in England. Participants will be briefed on the three new Investment and Impact Fund (IIF) medication safety searches that have been developed by PRIMIS and hear about a new Structured Medication Review (SMR) Toolkit developed by NHS Nottingham and Nottinghamshire CCG, which incorporates the PINCER indicators. Pharmacists will:

• Learn how PINCER can help them with their SMRs
• Understand the need for the new IIF searches and find out how to access them
• See a demonstration of the SMR Toolkit in action 

-------

Choice 2:

Heart Failure - Speaker: Helen Williams

-------

Choice 3:

Embedding a GPCP workforce - Speaker: Jalak Shukla

-------

 

Choice 4:

-------

Exhibition session 2 14.00 - 14.15

Choice 1:

The Impact of Choosing the Right Inhaler for Patients - Dr Omar Usmani 

This promotional educational session has been sponsored by CHIESI and are intended for UK Healthcare Professionals only

-------

Choice 2:

.......

-------

Choice 3:

Oral Nutritional Supplements – is fibre the forgotten nutrient?

This session will consider the general role of Fibre in Oral Nutrition Supplements and consider it’s importance for patient’s within the care home setting

This promotional educational session has been organised and fully funded by AYMES and are intended for UK Healthcare Professionals only

-------

Choice 4:

PCN case study: diabetes medicines optimisation of DPP-4is
• The need for diabetes medicines optimisation in the current climate
• Presentation of PCN switch case study
• Outcomes and results: continuity of care and NHS cost savings

This promotional educational session has been organised and fully funded by Takeda and are intended for UK Healthcare Professionals only.

-------

Workshop session 2 14.25 - 15.05

Choice 1:

Diabetes Patient Care and Medicines Optimisation - Speakers: Denise Rabbette & Professor Vinod Patel

• Management of diabetes patients – priorities and COVID-19 impact
• Overview of the Diabetes GIRFT Programme National Specialty Report – the opportunity to improve diabetes care
• Q&A session.

This promotional educational session has been organised and fully funded by TAKEDA and are intended for UK Healthcare Professionals only. This meeting is not organised by GIRFT or anybody who works for GIRFT.

-------

 

Choice 2:

**WORKSHOP FULL - Please make an alternative selection** De-Prescribing High Risk Drugs in the Elderly - Speakers: Lelly Oboh & Graham Stretch

• List common high-risk medicines in older people and explain why they need deprescribing
• Describe a process for safe and effective deprescribing of these drugs during Structured Medication Reviews (SMRs)
• Identify opportunities to collaborate with other members of the multidisciplinary team (MDT) for safe and effective deprescribing

-------

Choice 3:

Transitioning from Pre-registration to Foundation Training - Speakers: Jennifer Guffie, HEE & Suraj Varia, HEE

• HEE GP PRP programme – update
• Benefits of having a PRP in a GP practice
• Changes to initial education and training of pharmacists (GPhC IET) – what does this mean for general practice?

-------

Choice 4:

-------